vs

Side-by-side financial comparison of Intuitive Surgical (ISRG) and Marvell Technology, Inc. (MRVL). Click either name above to swap in a different company.

Intuitive Surgical is the larger business by last-quarter revenue ($2.8B vs $2.1B, roughly 1.3× Marvell Technology, Inc.). Marvell Technology, Inc. runs the higher net margin — 91.7% vs 29.8%, a 61.8% gap on every dollar of revenue. On growth, Marvell Technology, Inc. posted the faster year-over-year revenue change (36.8% vs 23.0%). Over the past eight quarters, Marvell Technology, Inc.'s revenue compounded faster (20.6% CAGR vs 17.4%).

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.

Marvell Technology, Inc. is an American company, headquartered in Santa Clara, California, which develops and produces semiconductors and related technology. Founded in 1995, the company had more than 6,500 employees as of 2024, with over 10,000 patents worldwide, and an annual revenue of $5.5 billion for fiscal 2024.

ISRG vs MRVL — Head-to-Head

Bigger by revenue
ISRG
ISRG
1.3× larger
ISRG
$2.8B
$2.1B
MRVL
Growing faster (revenue YoY)
MRVL
MRVL
+13.9% gap
MRVL
36.8%
23.0%
ISRG
Higher net margin
MRVL
MRVL
61.8% more per $
MRVL
91.7%
29.8%
ISRG
Faster 2-yr revenue CAGR
MRVL
MRVL
Annualised
MRVL
20.6%
17.4%
ISRG

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ISRG
ISRG
MRVL
MRVL
Revenue
$2.8B
$2.1B
Net Profit
$826.0M
$1.9B
Gross Margin
66.1%
51.6%
Operating Margin
17.2%
Net Margin
29.8%
91.7%
Revenue YoY
23.0%
36.8%
Net Profit YoY
17.4%
381.1%
EPS (diluted)
$2.28
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISRG
ISRG
MRVL
MRVL
Q1 26
$2.8B
Q4 25
$2.9B
$2.1B
Q3 25
$2.5B
$2.0B
Q2 25
$2.4B
$1.9B
Q1 25
$2.3B
$1.8B
Q4 24
$2.4B
$1.5B
Q3 24
$2.0B
$1.3B
Q2 24
$2.0B
$1.2B
Net Profit
ISRG
ISRG
MRVL
MRVL
Q1 26
$826.0M
Q4 25
$794.8M
$1.9B
Q3 25
$704.4M
$194.8M
Q2 25
$658.4M
$177.9M
Q1 25
$698.4M
$200.2M
Q4 24
$685.7M
$-676.3M
Q3 24
$565.1M
$-193.3M
Q2 24
$526.9M
$-215.6M
Gross Margin
ISRG
ISRG
MRVL
MRVL
Q1 26
66.1%
Q4 25
66.4%
51.6%
Q3 25
66.4%
50.4%
Q2 25
66.3%
50.3%
Q1 25
64.7%
50.5%
Q4 24
68.0%
23.0%
Q3 24
67.4%
46.2%
Q2 24
68.3%
45.5%
Operating Margin
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
30.2%
17.2%
Q3 25
30.3%
14.5%
Q2 25
30.5%
14.3%
Q1 25
25.7%
12.9%
Q4 24
30.4%
-46.4%
Q3 24
28.3%
-7.9%
Q2 24
28.2%
-13.1%
Net Margin
ISRG
ISRG
MRVL
MRVL
Q1 26
29.8%
Q4 25
27.7%
91.7%
Q3 25
28.1%
9.7%
Q2 25
27.0%
9.4%
Q1 25
31.0%
11.0%
Q4 24
28.4%
-44.6%
Q3 24
27.7%
-15.2%
Q2 24
26.2%
-18.6%
EPS (diluted)
ISRG
ISRG
MRVL
MRVL
Q1 26
$2.28
Q4 25
$2.19
$2.20
Q3 25
$1.95
$0.22
Q2 25
$1.81
$0.20
Q1 25
$1.92
$0.23
Q4 24
$1.89
$-0.78
Q3 24
$1.56
$-0.22
Q2 24
$1.46
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISRG
ISRG
MRVL
MRVL
Cash + ST InvestmentsLiquidity on hand
$2.7B
Total DebtLower is stronger
$4.5B
Stockholders' EquityBook value
$17.6B
$14.1B
Total Assets
$20.1B
$21.6B
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
$5.9B
$2.7B
Q3 25
$4.9B
$1.2B
Q2 25
$5.3B
$885.9M
Q1 25
$4.5B
$948.3M
Q4 24
$4.0B
$868.1M
Q3 24
$4.2B
$808.7M
Q2 24
$4.8B
$847.7M
Total Debt
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
$4.5B
Q3 25
$4.5B
Q2 25
$4.2B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$4.1B
Stockholders' Equity
ISRG
ISRG
MRVL
MRVL
Q1 26
$17.6B
Q4 25
$17.8B
$14.1B
Q3 25
$16.9B
$13.4B
Q2 25
$17.8B
$13.3B
Q1 25
$17.1B
$13.4B
Q4 24
$16.4B
$13.4B
Q3 24
$15.6B
$14.2B
Q2 24
$14.7B
$14.5B
Total Assets
ISRG
ISRG
MRVL
MRVL
Q1 26
$20.1B
Q4 25
$20.5B
$21.6B
Q3 25
$19.4B
$20.6B
Q2 25
$20.2B
$20.0B
Q1 25
$19.2B
$20.2B
Q4 24
$18.7B
$19.7B
Q3 24
$17.7B
$20.3B
Q2 24
$16.6B
$20.5B
Debt / Equity
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
0.32×
Q3 25
0.33×
Q2 25
0.32×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.29×
Q2 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISRG
ISRG
MRVL
MRVL
Operating Cash FlowLast quarter
$582.3M
Free Cash FlowOCF − Capex
$508.8M
FCF MarginFCF / Revenue
24.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
0.31×
TTM Free Cash FlowTrailing 4 quarters
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
$892.5M
$582.3M
Q3 25
$841.0M
$461.6M
Q2 25
$715.4M
$332.9M
Q1 25
$581.6M
$514.0M
Q4 24
$822.6M
$536.3M
Q3 24
$706.5M
$306.4M
Q2 24
$620.5M
$324.5M
Free Cash Flow
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
$730.0M
$508.8M
Q3 25
$735.6M
$414.1M
Q2 25
$560.1M
$214.1M
Q1 25
$465.0M
$444.1M
Q4 24
$510.6M
$461.3M
Q3 24
$458.6M
$258.2M
Q2 24
$311.1M
$233.0M
FCF Margin
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
25.5%
24.5%
Q3 25
29.4%
20.6%
Q2 25
23.0%
11.3%
Q1 25
20.6%
24.4%
Q4 24
21.2%
30.4%
Q3 24
22.5%
20.3%
Q2 24
15.5%
20.1%
Capex Intensity
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
5.7%
3.5%
Q3 25
4.2%
2.4%
Q2 25
6.4%
6.3%
Q1 25
5.2%
3.8%
Q4 24
12.9%
4.9%
Q3 24
12.2%
3.8%
Q2 24
15.4%
7.9%
Cash Conversion
ISRG
ISRG
MRVL
MRVL
Q1 26
Q4 25
1.12×
0.31×
Q3 25
1.19×
2.37×
Q2 25
1.09×
1.87×
Q1 25
0.83×
2.57×
Q4 24
1.20×
Q3 24
1.25×
Q2 24
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISRG
ISRG

Instruments and accessories$1.7B61%
Systems$650.7M23%
Services$433.7M16%

MRVL
MRVL

Segment breakdown not available.

Related Comparisons